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Polytetrafluoroethylene fume–induced pulmonary
edema: a case report and review of the literature
Rikuta Hamaya1, Yuko Ono1,2*, Yasuyuki Chida1, Ryota Inokuchi3,4, Ken Kikuchi5, Tadanobu Tameda6,
Choichiro Tase2 and Kazuaki Shinohara1
Abstract
Introduction: Polytetrafluoroethylene is ubiquitous in materials commonly used in cooking and industrial
applications. Overheated polytetrafluoroethylene can generate toxic fumes, inducing acute pulmonary edema in
some cases. However, neither the etiology nor the radiological features of this condition have been determined.
For clarification, we report an illustrative case, together with the first comprehensive literature review.
Case presentation: A previously healthy 35-year-old Japanese man who developed severe dyspnea presented
to our hospital. He had left a polytetrafluoroethylene-coated pan on a gas-burning stove for 10 hours while
unconscious. Upon admission, he was in severe respiratory distress. A chest computed tomographic scan showed
massive bilateral patchy consolidations with ground-glass opacities and peripheral area sparing. A diagnosis of
polytetrafluoroethylene fume–induced pulmonary edema was made. He was treated with non-invasive positive
pressure ventilation and a neutrophil elastase inhibitor, which dramatically alleviated his symptoms and improved
his oxygenation. He was discharged without sequelae on hospital day 11. A literature review was performed to
survey all reported cases of polytetrafluoroethylene fume–induced pulmonary edema. We searched the PubMed,
Embase, Web of Science and OvidSP databases for reports posted between the inception of the databases and 30
September 2014, as well as several Japanese databases (Ichushi Web, J-STAGE, Medical Online, and CiNii). Two
radiologists independently interpreted all chest computed tomographic images. Eighteen relevant cases (including
the presently reported case) were found. Our search revealed that (1) systemic inflammatory response syndrome
was frequently accompanied by pulmonary edema, and (2) common computed tomography findings were bilateral
ground-glass opacities, patchy consolidation and peripheral area sparing. Pathophysiological and radiological
features were consistent with the exudative phase of acute respiratory distress syndrome. However, the contrast
between the lesion and the spared peripheral area was striking and was distinguishable from the common
radiological features of acute respiratory distress syndrome.
Conclusion: The essential etiology of polytetrafluoroethylene fume–induced pulmonary edema seems to be
increased pulmonary vascular permeability caused by an inflammatory response to the toxic fumes. The radiological
findings that distinguish polytetrafluoroethylene fume–induced pulmonary edema can be bilateral ground-glass
opacity or a patchy consolidation with clear sparing of the peripheral area.
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Pulmonary inflammation, Radiological features, Teflon®, Toxic fumes
* Correspondence: windmill@fmu.ac.jp
1Department of Anesthesiology and Critical Care Medicine, Ohta General
Hospital Foundation, Ohta Nishinouchi Hospital, 2-5-20 Nishinouchi,
Koriyama, Fukushima 963-8558, Japan
2Emergency and Critical Care Medical Center, Fukushima Medical University
Hospital, 1 Hikarigaoka, Fukushima 960-1295, Japan
Full list of author information is available at the end of the article
JOURNAL OF MEDICAL
CASE REPORTS
© 2015 Hamaya et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Hamaya et al. Journal of Medical Case Reports  (2015) 9:111 
DOI 10.1186/s13256-015-0593-9
Introduction
Polytetrafluoroethylene (PTFE), or Teflon® (DuPont,
Wilmington, DE, USA), is ubiquitous in materials com-
monly used in cooking and industrial applications owing
to its thermal stability and non-stick properties. How-
ever, overheated PTFE generates toxic fumes that can
occasionally cause acute pulmonary edema [1-16]. To
date, neither the etiology nor the radiological features of
PTFE fume–induced pulmonary edema has been deter-
mined [1-16]. We therefore report an illustrative case
and have conducted the first comprehensive literature
review to clarify the etiology and radiological features of
PTFE fume–induced pulmonary edema.
Case presentation
A previously healthy 35-year-old Japanese man was
admitted to our hospital with dyspnea and dry cough.
He had fallen asleep while leaving a PTFE-coated pan on
the stove, which caught fire. He awoke 10 hours later
with severe dyspnea and noticed that the room was filled
with white smoke. The PTFE coating of the pan was
completely burned off, although the fire had not spread
outside the pan. Upon admission, his vital signs were as
follows: body temperature, 37.1°C; heart rate, 100 beats/
min; blood pressure, 131/97mmHg; respiratory rate, 30
breaths/min; and percutaneous oxygen saturation, 98%
(on oxygen 10L/min via a non-rebreather mask). The
patient was alert and denied using any medications, in-
cluding illicit drugs. Auscultation revealed bilateral
coarse crackles. His white blood cell count was 22,100/
μl with 91.2% neutrophils, and his arterial oxygen pres-
sure was 233.5mmHg while he was on 10L/min oxygen.
A chest X-ray showed bilateral infiltration (Figure 1A).
Chest computed tomography (CT) revealed massive, bi-
lateral, patchy consolidations with ground-glass opacities
and sparing of the peripheral areas (Figure 1B). These
lesions were distributed in a dorsally dominant manner
(Figure 1B). The patient’s echocardiogram and electro-
cardiogram were normal, so a diagnosis of PTFE fume–
induced, non-cardiogenic pulmonary edema with systemic
inflammatory response syndrome (SIRS) was made. The
patient was admitted and treated with non-invasive posi-
tive pressure ventilation (NPPV) and intravenous sivelestat
(Elaspol®; Ono Pharmaceutical, Osaka, Japan). NPPV was
initiated in a setting of positive end-expiratory pressure of
8cmH2O and intravenous sivelestat at a dosage of 4.8 mg/
kg/day, which dramatically alleviated his symptoms and
improved his oxygenation on the day of admission. His
respiratory status rapidly improved, and a second chest
CT scan on day 9 revealed complete resolution of the infil-
trates (Figure 1B). The patient was discharged to home
without any sequelae on hospital day 11.
On 30 September 2014, we searched for all reported
cases of PTFE fume–induced pulmonary edema on the
Figure 1 Chest X-ray and computed tomographic scan obtained upon admission and on day 9 of hospitalization. (A) Bilateral infiltration shadows
were detected on admission (left), which had completely disappeared at day 9 (right). (B) On admission, bilateral patchy consolidations with
ground-glass opacities and sparing of peripheral areas were found (left). On day 9 of the patient’s hospitalization, these shadows had completely
disappeared (right).
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PubMed, Embase, Web of Science, OvidSP and several
Japanese databases (Ichushi Web, J-STAGE, Medical On-
line and CiNii), without language restriction and using the
following keywords: “polymer fume fever,” “Teflon®,”
“polytetrafluoroethylene,” “pulmonary/lung edema” and
“acute lung injury/acute respiratory distress syndrome
(ARDS).” Three of the authors (RH, YO and RI) perfor-
med independent screenings. Cross-referencing was per-
formed, and all the relevant case reports and studies were
included. We excluded the following: (1) cases without
evidence of pulmonary edema, (2) cases without an asso-
ciation with PTFE fumes and (3) academy meeting
abstracts. The search produced 121 articles, of which 17
were potential candidates [1-16]. Next, clinical features in-
cluding patient characteristics, the situation under which
exposure occurred, symptoms, treatment and outcome
were reviewed by three intensivists (RH, YO, and RI). One
report was excluded because of insufficient information
[3], leaving 16 reports and 17 relevant cases [1,2,4-16] for
inclusion in this review. The temperature of the over-
heated PTFE was estimated based on information in the
relevant reports (molding settings [4,5,11], cigarettes [17]
and an overheated pan [18]). SIRS was defined according
to the criteria originally proposed by the American
College of Chest Physicians/Society of Critical Care
Medicine Consensus Conference [19]. All CT images
of PTFE fume–induced pulmonary edema were inter-
preted independently by two chest radiologists (KK and
TT). The distribution of the disease and the dominant
lesion were also noted. Thirteen reports without CT find-
ings were excluded [1,4-14], resulting in four reports
[2,3,15,16] and eight cases ultimately being eligible for
inclusion in this review.
The clinical characteristics of PTFE fume–induced
pulmonary edema described in this review, including
our patient, are summarized in Table 1. The patient
demographics of the cases in the literature review con-
sisted of 16 men and 2 women, aged 21 to 59 years.
Many patients were smokers (12 of 18), and most did
not have any comorbidities (15 of 18). Among all of the
reports included here, seven cases involved exposure
to PTFE-containing materials in factories or labora-
tories, 6 cases were of patients who had smoked
PTFE-contaminated cigarettes and 5 reports described
exposure to fumes from overheating PTFE-coated kit-
chenware in the home. Common symptoms were dyspnea
(17 of 18), cough (12 of 18) and flu-like symptoms such as
fever (9 of 18) and chills (6 of 18). SIRS was frequently
present (10 of 18). All patients had evidence of exposure
to fumes developed from overheated (391 to 875°C) PTFE.
One patient was exposed to PTFE fumes for 9 hours and
died 5 hours after admission despite intensive treatment
that included intubation [11]. Neither NPPV nor neutro-
phil elastase inhibitor was used in previously reported
cases. Transbronchial lung biopsy was performed in one
case, which revealed marked neutrophil migration into
the alveoli with edema in the alveolar septa [12]. Table 2
shows the chest CT characteristics of PTFE fume–induced
pulmonary edema, including our patient. Four patients
underwent chest CT on the day of admission: two on day
2 and two on day 4. Common findings were ground-glass
opacities (eight of eight), peripheral area sparing (six of
eight) and patchy consolidation (four of eight). With the
exception of a single patient, these lesions were distributed
bilaterally (seven of eight) and predominantly on the back
in most cases (five of eight).
Discussion
To the best of our knowledge, this is the first systematic
review of PTFE fume–induced pulmonary edema. Because
of the ubiquity of this material, all health care providers
need to be aware of the characteristics of this disease. Our
search revealed that (1) the essential etiology can be in-
flammatory pulmonary vascular hyperpermeability, (2) the
radiological features can be bilateral ground-glass opacity
or a patchy consolidation with clear peripheral area spar-
ing and (3) the duration of PTFE fume exposure is a pos-
sible aggravating factor.
First, the essential etiology of PTFE fume–induced
pulmonary edema can be inflammatory pulmonary vas-
cular hyperpermeability. Flu-like symptoms and SIRS
frequently accompany exposure, which are probably as-
sociated with pulmonary inflammation as a result of the
toxic fumes. In one report, authors described the trans-
bronchial lung biopsy findings in a patient with PTFE
fume–induced pulmonary edema, revealing marked neu-
trophil migration into the alveoli with alveolar edema
[12]. In a laboratory study, remarkable neutrophil infil-
tration and an increased level of inflammatory cytokines
were found in the pulmonary lavage of rats that had
been exposed to PTFE fumes [20]. Both are consistent
with the pathological findings regarding the exudative
phase of ARDS. NPPV [21] and neutrophil elastase in-
hibitors [22] are known to work effectively in treating
disease of this etiology.
Second, the radiological features of PTFE fume–in-
duced pulmonary edema can be bilateral ground-glass
opacity or patchy consolidation with clear peripheral
area sparing. Bilateral ground-glass opacity and patchy
consolidation are consistent with the chest CT findings
regarding the exudative phase of ARDS, supporting the
above-mentioned etiology. However, the contrast between
the lesion and the spared peripheral area was striking, and
these characteristics were clearly distinguishable from the
common radiological features of ARDS. One plausible
explanation for the spared area is that it is more difficult
for the toxic fumes to reach the peripheral alveoli; con-
sequently, this area escapes inflammation. The other
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Table 1 Summary of clinical characteristics of polytetrafluoroethylene fume–induced pulmonary edemaa
Patient Authors Sex Age
(yr)
Comorbid
disease
Smoking Situation Overheated
temperature (°C)
Exposure
time
SIRS Symptoms Treatment Outcome
(treatment
period)
1 Harris et al. [1] Male 38 No N/R Heating PTFE extruder in an oven
at a laboratory
N/R N/R Yes Dyspnea Absolute rest Discharged
(1 day)
2 Lee et al. [11] Male 43 No N/R Molding PTFE-containing materials
at a factory, dayshift worker
>410 to 510 9 hr Yes Dyspnea, malaise Intubation,
antibiotics,
inotropics
Died (5 hr)
3 Lee et al. [11] Male 37 No Yes Foreman of patient 2, with job
different from that of patient 2
(monitoring, cutting and packing)
>410 to 510 9 hr
(intermittently
exposed)
No Dyspnea, fever, chest
pain, chills, malaise
O2 Discharged
(7 days)
4 Lee et al. [11] Male 22 No N/R Colleague of patient 2, a night
shift worker with job different
from that of patient 2 (monitoring,
cutting and packing)
>410 to 510 9 hr
(intermittently
exposed)
No Dyspnea, cough,
chest pain
N/R Discharged
(9 days)
5 Robbins et al. [4] Male 38 No Yes Welding PTFE-containing
materials at a factory.
>560 3 hr Yes Dyspnea, cough,
fever, chest pain
O2, antibiotics Discharged
(3 days)
6 Evans et al. [5] Male 49 No Yes Molding PTFE-containing
materials at a factory
740 1 hr N/A Dyspnea, cough,
fever, throat pain
O2 Discharged
(2 days)
7 Haugtomt et al. [8] Male 33 No N/R Sanding Teflon-coated surface
at a factory
N/R 15 min Yes Dyspnea, fever, chest
pain, blood sputum
Diuretics,
antibiotics,
dopamine, O2
Discharged
(7 days)
8 Brubaker et al. [6] Male N/R No Yes Smoking PTFE-contaminated
cigarettes during commute
470 to 812 <10 min N/A Dyspnea, cough,
chest pain, chills
N/R Discharged
(N/R)
9 Patel et al. [13] Male 40 No Yes Smoking PTFE-contaminated
cigarettes in the home
470 to 812 <10 min Yes Dyspnea, cough,
fever, chills
Albuterol Discharged
(2 days)
10 Tanino et al. [12] Female 25 No Yes Smoking PTFE-contaminated
cigarettes in the home
470 to 812 <10 minutes No Dyspnea, cough,
fever
Steroid Discharged
(10 days)
11 Silver et al. [9] Male 21 No Yes Smoking PTFE-contaminated
cigarettes at a factory
470 to 812 <10 min Yes Dyspnea, cough,
chills, nausea/
vomiting
Antibiotics Discharged
(1 day)
12 Strøm et al. [14] Male 36 No Yes Smoking PTFE-contaminated
cigarettes in the home
470 to 812 <10 min Yes Dyspnea, chills Antibiotics,
O2
Improved
(1 day)
13 Myhre et al. [7] Male 25 No Yes Smoking PTFE-contaminated
cigarettes during commute
470 to 812 <10 min N/A Dyspnea, chills,
cough, headache
N/R Improved
(19 hr)
14 Shimizu et al. [2] Male 29 No N/R Overheating PTFE-coated pan
on fire in the home
>391 6 hr No Dyspnea, cough O2 Discharged
(3 days)
15 Toyama et al. [16] Male 59 OSAS Yes Overheating PTFE-coated
kitchenware in oven in the home
>391 4 hr Yes Fever, throat pain O2, diuretics Discharged
(9 days)
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Table 1 Summary of clinical characteristics of polytetrafluoroethylene fume–induced pulmonary edemaa (Continued)
16 Son et al. [15] Male 30 BA Yes Overheating PTFE-coated pan
on fire in the home
>391 7 hr No Dyspnea, cough,
fever
Observation Discharged
(6 days)
17 Zanen et al. [10] Female 26 Wilms’
tumor
No Overheating PTFE-coated
kitchenware in microwave
oven in the home
>391 <10 min Yes Dyspnea, cough,
fever, chest pain
O2, steroid Discharged
(1 day)
18 Our patient Male 35 No Yes Overheating PTFE coated
pan on fire in the home
>391 10 hours Yes Dyspnea, cough NPPV,
sivelestat
Discharged
(11 days)
aBA, Bronchial asthma; N/A, Not available; NPPV, Non-invasive positive pressure ventilation; N/R, Not recorded; OSAS, Obstructive sleep apnea syndrome; PTFE, Polytetrafluoroethylene; SIRS, Systemic inflammatory
response syndrome.
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explanation is related to the characteristics of lymph flow
in the lungs. Tiny particles in PTFE fumes may be re-
moved by the lymphatic drainage system, directly or by
means of macrophage ingestion and migration [23]. The
lymph proceeds in two opposite directions: centripetally
in the center of the lung and centrifugally in the periphery
[23,24]. Centrifugal lymph flow in the lung periphery may
effectively remove PTFE particles to the pleural lym-
phatics rather than centripetally by means of the lymph
flow to the hilum [23]. Dorsally dominant infiltration can
also be shown by the characteristic of the lymph flow in
the lungs. Lymphatic function is known to be poorest in
dorsal lungs, resulting in poor clearance of particles [23].
The above-mentioned radiologic features can be helpful in
making a diagnosis.
We also noted that a temperature of approximately
400°C may be the threshold for developing PTFE fume–
induced pulmonary edema in humans. Animal studies
involving rats have shown the development of lethal pul-
monary edema when the rats were exposed to fumes
produced by overheated PTFE at around 450°C [25],
which is consistent with our findings.
Finally, the duration of PTFE fume exposure is a pos-
sible aggravating factor. Lee and colleagues proposed a
dose–response relationship between PTFE fume expos-
ure and disease severity in that the most heavily exposed
worker (patient 2) died, whereas less-exposed workers
(patient 3, a foreman not restricted to the PTFE room;
and patient 4, a nightshift molder) recovered [11]. Our
survey also supports this finding. Lesser-exposed pa-
tients, such as those whose PTFE fume exposure was re-
lated to smoking, recovered quickly, whereas more
heavily exposed patients, such as our patient, required
longer treatment periods. As discussed, the patient who
was exposed to PTFE fumes for 9 hours died despite in-
tubation [11]. In comparison, we successfully treated a
similar patient (exposed to fumes for 10 hours) with
NPPV and early administration of a neutrophil elastase in-
hibitor, suggesting that these are suitable treatments for
cases involving pulmonary edema of this etiology [21,22].
Conclusions
Our experience with our patient, as well as our literature
review, suggest that the essential etiology of PTFE
fume–induced pulmonary edema is increased pulmonary
vascular permeability caused by an inflammatory response
to the toxic fumes. The CT findings that distinguish PTFE
fume–induced pulmonary edema can be bilateral ground-
glass opacity or a patchy consolidation with clear periph-
eral area sparing.
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Written informed consent was obtained from the patient
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Table 2 Chest computed tomography characteristics of
polytetrafluoroethylene fume–induced pulmonary edema
PTFE fume–induced pulmonary
edema patients, n = 8 (%)
Graphic pattern
Patchy consolidation 4 (50)
Ground-glass opacity 8 (100)
Peripheral area sparing 6 (75)
Interlobular septal thickening 2 (25)
Distribution
Bilateral 7 (87.5)
Unilateral 1 (12.5)
Dominant lesion
Dorsal 5 (62.5)
Ventral 1 (12.5)
No dominant lesion 2 (25.0)
CT, Computed tomography; PTFE, Polytetrafluoroethylene.
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